People In Brief: Sanofi Chief Patient Officer, New Leaders At DSM, NAI And KonaRed
This article was originally published in The Tan Sheet
Sanofi appoints chief patient officer; DSM names new leaders; marketing VP leaves Immunotec; Nutrition Zone names president; NAI names VP global sales; Kyowa Hakko USA hires sales manager; KonaRed appoints CFO, board member; Deloitte adds director of research.
You may also be interested in...
Woodcock’s willingness to stay on at US FDA for more than a transitional period after Robert Califf’s expected confirmation as commissioner may depend on exactly the type of authority and tasks he’d be willing to delegate to her. Plus, some other agency personnel updates.
The USP’s general chapter on nitrosamine impurities provides guidance on assessing risks and testing levels of the carcinogens in pharmaceuticals.
Novartis hopes a CAR-T with rapid manufacturing will be a winner, while novel bispecific antibodies in lymphoma and myeloma will make appearances, along with next-generation PI3K and BTK inhibitors.